Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advantan versus Protopic in children and adolescents with atopic dermatitis
2004-002099-40Phase 4Completed
- Sponsor
- Schering AG
- Start
- May 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in atopic dermatitis (AD) comparing Advantan once daily with Protopic 0.03% twice daily (2 arms). Primary endpoint: Investigator's Global Assessment success rate. Started May 2005; status: completed.
02
Drugs
methylprednisolone aceponateEnvarsus XR
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2004-002099-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002099-40.